CDRH 483s Will Include Language Developed Under GMP Initiative
This article was originally published in The Gray Sheet
FDA is seeking to reconcile device Form 483s with new language being added to drug inspection documents under the auspices of CDER's GMP initiative, according to FDA Assistant Commissioner of Regulatory Affairs Steve Niedelman
You may also be interested in...
FDA's initiative to enhance pharmaceutical good manufacturing practices will apply to combination products that have biological drug or drug components
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.